ActivX Biosciences, Inc. uses its proprietary technology to identify target and off-target activities of drug candidates in the protein kinase and protease families. The company's core technology is intended to allow the identification and development of highly selective drugs, lowering development risk.

🔗 http://activx.com

CONNECT:

Lorrie Daggett, Chief Operating Officer
📧 lorried@activx.com
📞 858.526.2505
11025 N. Torrey Pines Road, Suite 120
La Jolla, CA 92037